NCT02350452

Brief Summary

Endometriosis is a benign chronic gynaecological disease that affects 10% of women of reproductive age and takes 40% of them to assisted reproduction techniques. The purpose of the study is to compare the antimüllerian marker (AMH) and antral follicular count (AFC) , with the most common serological markers of ovarian reserve. The investigators intend to confirm their clinical utility in the assessment of ovarian function, and to promote their use in predicting decreased ovarian reserve. The work therefore moreover arises the objective to validate the bibliographic data about using the laser for haemostasis after stripping endometriomas, to amplify knowledge available in the literature on the surgical treatment of ovarian endometriomas and on the diode laser application in minimally invasive surgery, appraising the trend of AFC and AMH levels and the possible surgical implications on fertility .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

January 19, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 29, 2015

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
Last Updated

April 22, 2016

Status Verified

April 1, 2016

Enrollment Period

7 months

First QC Date

January 19, 2015

Last Update Submit

April 21, 2016

Conditions

Keywords

laparoscopic surgerydiode laserAMHAFC

Outcome Measures

Primary Outcomes (1)

  • Anti-Müllerian hormone (AMH) serum levels

    Change from AMH serum levels at 3 months after surgery

Secondary Outcomes (1)

  • Antral follicular count (AFC)

    Change from AFC at 3 months after surgery, during early follicular phase

Study Arms (2)

Diode laser coagulation

EXPERIMENTAL

Diode laser coagulation of inner lining of ovarian endometrioma after laparoscopic cystectomy

Procedure: Diode laser coagulation

Bipolar coaugulation

ACTIVE COMPARATOR

Bipolar coagulation of inner lining of ovarian endometrioma after laparoscopic cystectomy

Procedure: Bipolar coagulation

Interventions

Diode laser coagulation of inner lining of ovarian endometrioma after laparoscopic cystectomy

Diode laser coagulation

Bipolar coagulation of inner lining of ovarian endometrioma after laparoscopic cystectomy

Bipolar coaugulation

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • regular menstrual cycles
  • unilateral endometrioma greater than 35 mm
  • no gynecological surgery 3-6 months before surgery
  • no hormonal therapy 1 month before surgery

You may not qualify if:

  • previous surgery for endometriosis
  • hormone therapy in the month before the current surgery
  • coagulation disorders
  • ongoing pregnancy
  • pelvic inflammatory disease
  • malignant disorders
  • cysts otherwise
  • Gonadotropin-releasing hormone analogues or contraceptive therapy during the follow-up
  • BMI≥ 30 kg/m2
  • endocrinological disorders
  • unable or unwilling to give written consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Cagliari,Obstetrics and Gynecological Department,

Monserrato, Cagliari, 09042, Italy

Location

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 19, 2015

First Posted

January 29, 2015

Study Start

January 1, 2015

Primary Completion

August 1, 2015

Study Completion

February 1, 2016

Last Updated

April 22, 2016

Record last verified: 2016-04

Locations